Literature DB >> 22036886

Financing and systems barriers to seasonal influenza vaccine delivery in community settings.

Robert B Penfold1, Donna Rusinak, Tracy A Lieu, Abigail Shefer, Mark Messonnier, Grace M Lee.   

Abstract

BACKGROUND: Recommendations for annual seasonal influenza vaccination have expanded to now include >300 million children and adults each year. Community settings have become increasingly important venues for influenza vaccination. We sought to identify barriers to and solutions for expanding influenza vaccination in community settings.
METHODS: Semi-structured telephone interviews were conducted from 01/09 to 06/10 with a range of stakeholders involved in influenza vaccination, including health plans, medical services firms, retail based clinics, pharmacies, schools, and state and local public health immunization programs. Participants (n=65) were asked about barriers and feasible solutions to influenza vaccine delivery to children and adults in community settings. Key themes were identified through iterative coding using a grounded theory approach.
RESULTS: Stakeholders identified specific financial barriers to influenza vaccine delivery in 3 major areas: purchase and distribution, delivery, and reimbursement. Limited purchasing power, the uncertain nature of public demand, and unpredictable timing of influenza vaccine supply were important barriers to enhance delivery in community settings. Barriers to delivery included complexities in running off-site clinics, especially in school settings, the need to manage publicly vs. privately purchased vaccines separately, and state-to-state variability in requirements for credentialing, physician oversight, and reporting. Reimbursement barriers included a protracted credentialing process, the need to determine insurance eligibility at point-of-service, and lack of a billing infrastructure in off-site clinics. Opportunities to mitigate financial barriers to influenza vaccine delivery in community settings focused on coordination across providers and the role of public health as a "trusted broker" to overcome existing challenges.
CONCLUSIONS: Financial and systems barriers hamper the optimal use of community settings to effectively deliver influenza vaccines. Public health partners at the federal, state, and local levels are well-positioned to facilitate the engagement of all stakeholders in this important and complex vaccine delivery system.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036886     DOI: 10.1016/j.vaccine.2011.10.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Community pharmacies as sites of adult vaccination: A systematic review.

Authors:  Randall C Burson; Alison M Buttenheim; Allison Armstrong; Kristen A Feemster
Journal:  Hum Vaccin Immunother       Date:  2016-08-15       Impact factor: 3.452

2.  Billing practices of local health departments providing 2009 pandemic influenza A (H1N1) vaccine.

Authors:  Megan C Lindley
Journal:  J Public Health Manag Pract       Date:  2013 May-Jun

3.  Galvanizing medical students in the administration of influenza vaccines: the Stanford Flu Crew.

Authors:  Rachel E Rizal; Rishi P Mediratta; James Xie; Swetha Kambhampati; Kelsey Hills-Evans; Tamara Montacute; Michael Zhang; Catherine Zaw; Jimmy He; Magali Sanchez; Lauren Pischel
Journal:  Adv Med Educ Pract       Date:  2015-07-01

4.  Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.

Authors:  Frank Andersohn; Reinhard Bornemann; Oliver Damm; Martin Frank; Thomas Mittendorf; Ulrike Theidel
Journal:  GMS Health Technol Assess       Date:  2014-10-30

5.  National community pharmacy NHS influenza vaccination service in Wales: a primary care mixed methods study.

Authors:  Andrew M Evans; Fiona C Wood; Ben Carter
Journal:  Br J Gen Pract       Date:  2016-03-10       Impact factor: 5.386

6.  Clinicians' and Pharmacists' Reported Implementation of Vaccination Practices for Adults.

Authors:  Chelsea S Lutz; David K Kim; Carla L Black; Sarah W Ball; Rebecca G Devlin; Anup Srivastav; Amy Parker Fiebelkorn; Carolyn B Bridges
Journal:  Am J Prev Med       Date:  2018-07-24       Impact factor: 5.043

7.  Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease.

Authors:  Arintaya Phrommintikul; Wanwarang Wongcharoen; Srun Kuanprasert; Narawudt Prasertwitayakij; Rungsrit Kanjanavanit; Siriluck Gunaparn; Apichard Sukonthasarn
Journal:  J Geriatr Cardiol       Date:  2014-06       Impact factor: 3.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.